Colchicine for Community-Treated Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Colchicine for Community-Treated Patients With COVID-19 (COLCORONA): A Phase 3, Randomised, Double-Blinded, Adaptive, Placebo-Controlled, Multicentre Trial
Lancet Respir Med 2021 May 27;[EPub Ahead of Print], JC Tardif, N Bouabdallaoui, PL L'Allier, D Gaudet, B Shah, MH Pillinger, J Lopez-Sendon, P da Luz, L Verret, S Audet, J Dupuis, A Denault, M Pelletier, PA Tessier, S Samson, D Fortin, JD Tardif, D Busseuil, E Goulet, C Lacoste, A Dubois, AY Joshi, DD Waters, P Hsue, NE Lepor, F Lesage, N Sainturet, E Roy-Clavel, Z Bassevitch, A Orfanos, G Stamatescu, JC Grégoire, L Busque, C Lavallée, PO Hétu, JS Paquette, SG Deftereos, S Levesque, M Cossette, A Nozza, M Chabot-Blanchet, MP Dubé, MC Guertin, G BoivinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.